|
1
|
Schmidt J, Kunderova M, Pilbauerova N and
Kapitan M: A review of evidence-based recommendations for
pericoronitis management and a systematic review of antibiotic
prescribing for pericoronitis among dentists: Inappropriate
pericoronitis treatment is a critical factor of antibiotic overuse
in dentistry. Int J Environ Res Public Health.
18(6796)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Singh P, Nath P, Bindra S, Rao SS and
Reddy KR: The predictivity of mandibular third molar position as a
risk indicator for pericoronitis: A prospective study. Natl J
Maxillofac Surg. 9:215–221. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nitzan DW, Tal O, Sela MN and Shteyer A:
Pericoronitis: A reappraisal of its clinical and microbiologic
aspects. J Oral Maxillofac Surg. 43:510–516. 1985.PubMed/NCBI View Article : Google Scholar
|
|
4
|
McArdle LW and Renton T: The effects of
NICE guidelines on the management of third molar teeth. Br Dent J.
213(E8)2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
World Health Organization (WHO):
International Statistical Classification of Diseases and Related
Health Problems. 10th revision. WHO, Geneva, pICD-10, 2010.
|
|
6
|
Phillips C, Norman J, Jaskolka M, Blakey
GH, Haug RH, Offenbacher S and White RP Jr: Changes over time in
position and periodontal probing status of retained third molars. J
Oral Maxillofac Surg. 65:2011–2017. 2007.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Maruta T and Matsumoto C: Renaming
schizophrenia. Epidemiol Psychiatr Sci. 28:262–264. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Tiihonen J, Lönnqvist J, Wahlbeck K,
Klaukka T, Niskanen L, Tanskanen A and Haukka J: 11-year follow-up
of mortality in patients with schizophrenia: A population-based
cohort study (FIN11 study). Lancet. 374:620–627. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
World Health Organization (WHO): Chapter
5: Mental and behavioral disorders-Schizophrenia, schizotypal and
delusional disorders. In: International Statistical Classification
of Diseases and Related Health Problems. 10th Revision. WHO,
Geneva, ppF20-F29, 2019. https://icd.who.int/browse10/2019/en.
|
|
10
|
Galletly C, Castle D, Dark F, Humberstone
V, Jablensky A, Killackey E, Kulkarni J, McGorry P, Nielssen O and
Tran N: Royal Australian and New Zealand College of Psychiatrists
clinical practice guidelines for the management of schizophrenia
and related disorders. Aust NZJ Psychiatry. 50:410–472.
2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kay SR, Fiszbein A and Opler LA: The
positive and negative syndrome scale (PANSS) for Schizophrenia.
Schizophr Bull. 13:261–276. 1987.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Chua-Tuan JL: Surgical adverse outcomes in
patients with Schizophrenia: A population-based study. J Emerg Med.
5:1061–1062. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kudoh A: Perioperative management for
chronic schizophrenic patients. Anaesth Analg. 101:1867–1872.
2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Tanaka K, Budd MA, Efron ML and
Isselbacher KJ: Isovaleric acidemia: A new genetic defect of
leucine metabolism. Proc Natl Acad Sci USA. 56:236–242.
1966.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lin WD, Wang CH, Lee CC, Lai CC, Tsai Y
and Tsai FJ: Genetic mutation profile of isovaleric acidemia
patients in Taiwan. Mol Genet Metab. 90:134–139. 2007.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Ensenauer R, Vockley J, Willard JM, Huey
JC, Sass JO, Edland SD, Burton BK, Berry SA, Santer R, Grünert S,
et al: A common mutation is associated with a mild, potentially
asymptomatic phenotype in patients with isovaleric acidemia
diagnosed by newborn screening. Am J Hum Genet. 75:1136–1142.
2004.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Grünert SC, Wendel U, Lindner M,
Leichsenring M, Schwab KO, Vockley J, Lehnert W and Ensenauer R:
Clinical and neurocognitive outcome in symptomatic isovaleric
acidemia. Orphanet J Rare Dis. 7(9)2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tanaka K and Isselbacher KJ: The isolation
and identification of N-isovalerylglycine from urine of patients
with isovaleric acidemia. J Biol Chem. 242:2966–2972.
1967.PubMed/NCBI
|
|
19
|
Vockley J and Ensenauer R: Isovaleric
acidemia: New aspects of genetic and phenotypic heterogeneity. Am J
Med Genet C Semin Med Genet. 142:95–103. 2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Newman CG, Wilson BD, Callaghan P and
Young L: Neonatal death associated with isovalericacidaemia.
Lancet. 2:439–442. 1967.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Berry GT, Yudkoff M and Segai S:
Isovaleric acidemia: Medical and neurodevelopmental effects of
long-term therapy. J Pediatr. 113 (1 Pt 1):58–64. 1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tanaka K: Isovaleric acidemia: Personal
history, clinical survey and study of the molecular basis. Prog
Clin Biol Res. 321:273–290. 1990.PubMed/NCBI
|
|
23
|
Yeoh C, Teng H, Jackson J, Hingula L, Irie
T, Legler A, Levine C, Chu I, Chai C and Tollinche L: Metabolic
disorders and anaesthesia. Curr Anesthesiol Rep. 9:340–359.
2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mrad S, El Tawil C, Sukaiti WA, Bou Chebl
R, Abou Dagher G and Kazzi Z: Cardiac arrest following liposuction:
A case report of lidocaine toxicity. Oman Med J. 34:341–344.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Weinberg GL, Laurito CE, Geldner P, Pygon
BH and Burton BK: Malignant ventricular dysrhythmias in a patient
with isovaleric acidemia receiving general and local anaesthesia
for suction lipectomy. J Clin Anaesth. 9:668–670. 1997.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Holme E, Greter J, Jacobson CE, Lindstedt
S, Nordin I, Kristiansson B and Jodal U: Carnitine deficiency
induced by pivampicillin and pivmecillinam therapy. Lancet.
2:469–473. 1989.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Porto GG, Vasconcelos BC, Gomes AC and
Albert D: Evaluation of lidocaine and mepivacaine for inferior
third molar surgery. Med Oral Patol Oral Cir Bucal. 12:E60–E64.
2007.PubMed/NCBI
|
|
28
|
Šarac Z, Zovko R, Ćurlin M and Filaković
P: Dental medicine and psychiatry: The need for collaboration and
bridging the professional gap. Psychiatr Danub. 32:151–158.
2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Šimunović Filipčić I and Filipčić I:
Schizophrenia and physical comorbidity. Psychiatr Danub. 30 (Suppl
4):S152–S157. 2018.PubMed/NCBI
|
|
30
|
Jakovljevic M and Borovecki F:
Epigenetics, resilience, comorbidity and treatment outcome.
Psychiatr Danub. 30:242–253. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kudoh A, Katagai H, Takase H and Takazawa
T: Effect of preoperative discontinuation of antipsychotics in
schizophrenic patients on outcome during and after anaesthesia. Eur
J Anaesthesiol. 21:414–416. 2004.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Vreken P, Van Lint AE, Bootsma AH,
Overmars H, Wanders RJ and Van Gennip AH: Quantitative plasma
acylcarnitine analysis using electrospray tandem mass spectrometry
for the diagnosis of organic acidaemias and fatty acid oxidation
defects. J Inherit Metab Dis. 22:302–306. 1999.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Kelleher JF Jr, Yudkoff M, Hutchinson R,
August CS and Cohn RM: The pancytopenia of isovaleric acidemia.
Pediatrics. 65:1023–1027. 1980.PubMed/NCBI
|
|
34
|
Macfarlane AJR, Gitman M, Bornstein KJ,
El-Boghdadly K and Weinberg G: Updates in our understanding of
local anaesthetic systemic toxicity: A narrative review.
Anaesthesia. 76 (Suppl 1):S27–S39. 2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Elvir-Lazo OL, White PF, Cruz Eng H, Yumul
F, Chua R and Yumul R: Impact of chronic medications in the
perioperative period-anesthetic implications (Part II). Postgrad
Med. 133:920–938. 2021.PubMed/NCBI View Article : Google Scholar
|
